Corteva Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
Corteva Stock Forecast and Price Target
The average target price set lately by experts for Corteva to reach by the end of the year is $64.00, which would imply a potential upside of approximately 19.56 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $70.00 and a low estimate of $53.00. Even if you're not interested in CTVA stock, you may be interested in its competitors.
19.56% Upside
Corteva Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Corteva's Price has decreased from $32.70 to $0.00 – a 100.00% drop. In the next year, analysts predict that Fair Value will reach $73.47 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$144.77 | Buy/Sell | $174.55 | 17.43% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$125.37 | Buy/Sell | $130.51 | 10.87% |
| NESN Stock Forecast | Nestlé | Outperform |
11
|
CHF93.36 | Buy/Sell | CHF115.58 | 17.82% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£108.62 | Buy/Sell | £165.99 | 49.73% |
| HON Stock Forecast | Honeywell International Inc | Outperform |
12
|
$190.36 | Buy/Sell | $219.12 | 16.88% |
Corteva Revenue Forecast for 2023 - 2025 - 2030
Corteva's Revenue has grown in the last three years, jumping from $14.22B to $17.23B – an increase of 21.16%. In the next year, analysts predict that Revenue will reach $18.74B – an increase of 8.77%. For the next seven years, the forecast is for Revenue to grow by 28.94%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DE Stock Forecast | Deere & | Outperform |
5
|
$396.88 | Buy/Sell | $424.33 | 3.67% |
| BP. Stock Forecast | BP p.l.c. | Outperform |
9
|
£5.17 | Buy/Sell | £7.50 | 45.65% |
| AI Stock Forecast | L'Air Liquide | Outperform |
17
|
186.50€ | Buy/Sell | 178.09€ | 4.83% |
.jpg)
Corteva Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Corteva's Dividend per Share has increased by 21.15%, going from $0.52 to $0.63. In the next year, analysts are expecting an increase in Dividend per Share, predicting it will reach $0.68 – an increase of 7.94%. The Corteva forecast is for Dividend per Share to reach $0.96 or grow by 52.97%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$47.84 | Buy/Sell | $58.15 | 14.97% |
| ABBN Stock Forecast | ABB Ltd | Hold |
11
|
CHF41.72 | Buy/Sell | CHF42.44 | 5.70% |
| GSK Stock Forecast | GSK | Outperform |
12
|
£15.90 | Buy/Sell | £17.30 | 22.64% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EMR Stock Forecast | Emerson Electric Co | Outperform |
10
|
$109.81 | Buy/Sell | $109.83 | 13.03% |
| ECL Stock Forecast | Ecolab | Hold |
18
|
$219.25 | Buy/Sell | $205.36 | 5.36% |
| APD Stock Forecast | Air Products and Chemicals | Outperform |
16
|
$229.01 | Buy/Sell | $310.73 | 15.72% |
Corteva EBITDA Forecast for 2023 - 2025 - 2030
Corteva's EBITDA has increased by 34.72% In the last three years, going from $2.39B to $3.22B. In the next year, analysts expect EBITDA to reach $3.60B – an increase of 11.79%. For the next seven years, the forecast is for EBITDA to grow by 35.83%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAS Stock Forecast | BASF | Outperform |
12
|
50.97€ | Buy/Sell | 49.50€ | 9.87% |
| KMB Stock Forecast | Kimberly-Clark | Hold |
18
|
$125.96 | Buy/Sell | $128.04 | 6.38% |
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF522.40 | Buy/Sell | CHF516.89 | 11.98% |
Corteva EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Corteva's EBIT has grown, increasing from $1.21B to $2.01B – a growth of 65.65%. The next year looks promising for Corteva, with analysts predicting EBIT of $3.08B – an increase of 53.38%. Over the next seven years, experts anticipate that Corteva's EBIT will grow at a rate of 76.57%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DOW Stock Forecast | Dow | Hold |
2
|
$56.82 | Buy/Sell | $57.75 | 5.60% |
| GIVN Stock Forecast | Givaudan | Hold |
14
|
CHF3.88k | Buy/Sell | CHF3.14k | -0.72% |
| DD Stock Forecast | DuPont de Nemours | Outperform |
17
|
$73.09 | Buy/Sell | $75.38 | 9.45% |
Corteva EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Corteva's EPS has decreased from $1.50 to $0.00 – a 100.00% drop. In the next year, analysts predict that EPS will reach $3.37 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ADM Stock Forecast | Archer-Daniels-Midland | Hold |
8
|
$60.42 | Buy/Sell | $67.70 | 5.43% |
| HEN3 Stock Forecast | Henkel AG & Co. KGaA | Hold |
16
|
71.18€ | Buy/Sell | 71.63€ | 5.37% |
| DSFIR Stock Forecast | DSM-Firmenich | Outperform |
18
|
101.60€ | Buy/Sell | 114.60€ | 18.11% |
.jpg)